Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) CEO Joel Latham tells Proactive the company has begun the process of shifting all outstanding shares to the Nasdaq after making the decision to redomicile to the United States via a scheme of arrangement. He says the move will provide greater exposure to US markets and bring its market valuation in line with its value proposition. Incannex will give shareholders and option holders the opportunity to vote on redomiciling to the US in October 2023, anticipating a swift implementation of the Nasdaq listing should approval be given.
Incannex CEO talks plans to redomicile to US
